Evidence map›Paper›PMID 31525952›Full record

ArticleAnalytical chemistry2019

Nanoarray Digital Polymerase Chain Reaction with High-Resolution Melt for Enabling Broad Bacteria Identification and Pheno-Molecular Antimicrobial Susceptibility Test.

Pornpat Athamanolap, Kuangwen Hsieh, Christine M O'Keefe, Ye Zhang, Samuel Yang, Tza-Huei Wang

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Multiplex Digital Methylation-Specific PCR for Noninvasive Screening of Lung Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pornpat AthamanolapDepartment of Biomedical Engineering , Johns Hopkins School of Medicine , Baltimore , Maryland 21205 , United States.ORCID 0000-0001-6124-4955
Christine M O'KeefeDepartment of Biomedical Engineering , Johns Hopkins School of Medicine , Baltimore , Maryland 21205 , United States.
Ye ZhangDepartment of Biomedical Engineering , Johns Hopkins School of Medicine , Baltimore , Maryland 21205 , United States.ORCID 0000-0003-3057-6759
Samuel YangDepartment of Emergency Medicine , Stanford University , Stanford , California 94304 , United States.
Tza-Huei WangDepartment of Biomedical Engineering , Johns Hopkins School of Medicine , Baltimore , Maryland 21205 , United States.ORCID 0000-0002-3540-9354
Johns Hopkins University · USStanford University · US

Funding

A Droplet-based single cell platform for pathogen identification and ASTR01AI117032 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LIAO, JOSEPH C, WANG, TZA-HUEI JEFF · 2015 to 2019
$5.7M
Technology development for point-of-care detection and antimicrobial susceptibility testing of Neisseria gonorrhoeaeR01AI138978 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WANG, TZA-HUEI JEFF · 2018 to 2021
$5.1M
A "Culture" Shift: Integrated Bacterial Screening and Antibacterial Susceptibility Test on Microfluidic Digital Array for Bloodstream InfectionsR01AI137272 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WANG, TZA-HUEI JEFF, YANG, SAMUEL · 2018 to 2022
$3.6M
NIAID NIH HHS R01 AI117032NIAID NIH HHS R01 AI137272NIAID NIH HHS R01 AI138978
6 · The paper itself

Abstract

Toward combating infectious diseases caused by pathogenic bacteria, there remains an unmet need for diagnostic tools that can broadly identify the causative bacteria and determine their antimicrobial susceptibilities from complex and even polymicrobial samples in a timely manner. To address this need, a microfluidic and machine-learning-based platform that performs broad bacteria identification (ID) and rapid yet reliable antimicrobial susceptibility testing (AST) is developed. Specifically, this platform builds on "pheno-molecular AST", a strategy that transforms nucleic acid amplification tests (NAATs) into phenotypic AST through quantitative detection of bacterial genomic replication, and utilizes digital polymerase chain reaction (PCR) and digital high-resolution melt (HRM) to quantify and identify bacterial DNA molecules. Bacterial species are identified using integrated experiment-machine learning algorithm via HRM profiles. Digital DNA quantification allows for rapid growth measurement that reflects susceptibility profiles of each bacterial species within only 30 min of antibiotic exposure. As a demonstration, multiple bacterial species and their susceptibility profiles in a spiked-in polymicrobial urine specimen were correctly identified with a total turnaround time of ∼4 h. With further development and clinical validation, this platform holds the potential for improving clinical diagnostics and enabling targeted antibiotic treatments.

Indexed as

Anti-Bacterial AgentsBacteriaDNA, BacterialMachine LearningMicroarray AnalysisMicrobial Sensitivity TestsNanotechnologyPhenotypePolymerase Chain ReactionAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID31525952
PMCPMC8645066
OpenAlexW2974106063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.